Clobazam (Frisium) 10mg tablets: limited supply
The Frisium brand is short until about 9 October 2026. Clobazam is an MHRA category 1 antiepileptic, so take care when switching brands.
Showing: Guidance Everything, including news and events
Topics:Collective action & GPCContracts & fundingPCNs & neighbourhoodsVaccinations & screeningPrescribing & medicinesReferrals & hospital servicesPublic healthIT, data & cyber securityWorkforce & employmentCQC, regulation & governancePCSE & patient registrationFees & non-NHS workPremises & estatesWellbeing & supportBLMC news
The Frisium brand is short until about 9 October 2026. Clobazam is an MHRA category 1 antiepileptic, so take care when switching brands.
Run the ICB's EMIS search for patients recorded as penicillamine-allergic who may actually be penicillin-allergic, and review each record (TPP search to follow). It's a National Patient Safety Alert, so CQC may act if it's not done.
Resources to support good-quality urine sample collection for suspected UTIs.
Tirzepatide (Mounjaro): prescribers must make sure patients are referred to a behavioural support service as part of wraparound care.
Limited until about 25 September 2026. Don't start new patients on this preparation.
A poster listing community pharmacies stocking specialist palliative care drugs over bank holidays is in the BSol Medicines Management Hub.
Covers the CQC annual controlled drugs report, prevention of future deaths learning and preventing diversion.
Don't start new patients. See the SPS tool for alternatives.
MHRA advice: severe hypertension has been reported. Domperidone is now contraindicated where phaeochromocytoma is confirmed or suspected.
Cookies on this site. We’d like to use Google Analytics cookies to see which pages are used, so we can improve the site. They are not used for advertising.